Pfizer to merge generics unit with Mylan; seeks to sharpen cancer focus
July 29 (Reuters) - Drugmaker Pfizer Inc has agreed to spin off its generic drugs business and combine it with Mylan , a move that leaves Pfizer with more...
July 29 (Reuters) - Drugmaker Pfizer Inc has agreed to spin off its generic drugs business and combine it with Mylan , a move that leaves Pfizer with more...